Systematic Literature Review of Clinical, Economic, and Humanistic Outcomes Following Minimally Invasive Glaucoma Surgery or Selective Laser Trabeculoplasty for the Treatment of Open-Angle Glaucoma with or Without Cataract Extraction

References

• Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: the Past, Present, and Predictions for the Future. Cureus. 2020;12(11):e11686. doi:10.7759/cureus.11686
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/S0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911. doi:10.1001/jama.2014.3192
   PubMed Web of Science ®Google Scholar
• Diagnosis And Management. National Institute for Health and Care Excellence. Glaucoma: Diagnosis And Management; 2022.
   Google Scholar
• Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505–1516. doi:10.1016/S0140-6736(18)32213-X
   PubMed Web of Science ®Google Scholar
• Grabska-Liberek I, Duda P, Rogowska M, et al. 12-month interim results of a prospective study of patients with mild to moderate open-angle glaucoma undergoing combined viscodilation of Schlemm’s canal and collector channels and 360° trabeculotomy as a standalone procedure or combined with cataract surgery. Eur J Ophthalmol. 2022;32(1):309–315. doi:10.1177/1120672121998234
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Approval for the Glaukos iStent Trabecular Micro-Bypass Stent; 2012.
   Google Scholar
• Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189–206. doi:10.2147/OPTH.S80490
   PubMed Web of Science ®Google Scholar
• Buffault J, Baudouin C, Labbé A. Is the Xen® Gel Stent really minimally invasive? Am j Ophthalmol Case Rep. 2020;19:100850. doi:10.1016/j.ajoc.2020.100850
   PubMedGoogle Scholar
• Laroche D, Rickford K, Sakkari S. Case report: cataract extraction/lensectomy, excisional goniotomy and transscleral cyclophotocoagulation: affordable combination MIGS for plateau iris glaucoma. J Natl Med Assoc. 2022;114(1):38–41. doi:10.1016/j.jnma.2021.12.005
   Web of Science ®Google Scholar
• Fea AM, Ahmed II, Lavia C, et al. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results. Clin Experiment Ophthalmol. 2017;45(2):120–127. doi:10.1111/ceo.12805
   PubMed Web of Science ®Google Scholar
• Pérez-Torregrosa VT, Olate-Pérez Á, Cerdà-Ibáñez M, et al. Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol. 2016;91(9):415–421. doi:10.1016/j.oftal.2016.02.006
   PubMedGoogle Scholar
• Falkenberry S, Singh IP, Crane CJ, et al. Excisional goniotomy vs trabecular microbypass stent implantation: a prospective randomized clinical trial in eyes with mild to moderate open-angle glaucoma. J Cataract Refract Surg. 2020;46(8):1165–1171. doi:10.1097/j.jcrs.0000000000000229
   PubMed Web of Science ®Google Scholar
• Klamann MK, Maier AK, Gonnermann J, Ruokonen PC. Adverse effects and short-term results after selective laser trabeculoplasty. J Glaucoma. 2014;23(2):105–108. doi:10.1097/IJG.0b013e3182684fd1
   PubMed Web of Science ®Google Scholar
• Gallardo MJ, Sarkisian Jr SR Vold SD, et al. Canaloplasty and Trabeculotomy Combined with Phacoemulsification in Open-Angle Glaucoma: interim Results from the GEMINI Study. Clin Ophthalmol. 2021;15:481–489. doi:10.2147/OPTH.S296740
   PubMed Web of Science ®Google Scholar
• Pyfer MF, Gallardo M, Campbell A, et al. Suppression of Diurnal (9AM-4PM) IOP Fluctuations with Minimally Invasive Glaucoma Surgery: an Analysis of Data from the Prospective, Multicenter, Single-Arm GEMINI Study. Clin Ophthalmol. 2021;15:3931–3938. doi:10.2147/OPTH.S335486
   Web of Science ®Google Scholar
• Klabe K, Kaymak H. Standalone Trabeculotomy and Viscodilation of Schlemm’s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes. Clin Ophthalmol. 2021;15:3121–3129. doi:10.2147/OPTH.S325394
   PubMed Web of Science ®Google Scholar
• Patel I, de Klerk TA, Au L. Manchester iStent study: early results from a prospective UK case series. Clin Experiment Ophthalmol. 2013;41(7):648–652.
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Sarkisian SR, Lubeck DM, et al. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: two-Year Results. Ophthalmology. 2019;126(6):811–821. doi:10.1016/j.ophtha.2019.03.006
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. doi:10.1016/j.ophtha.2010.07.007
   PubMed Web of Science ®Google Scholar
• Konopińska J, Kozera M, Kraśnicki P, Mariak Z, Rękas M. The Effectiveness of First-Generation iStent Microbypass Implantation Depends on Initial Intraocular Pressure: 24-Month Follow-Up-Prospective Clinical Trial. J Ophthalmol. 2020;2020:8164703. doi:10.1155/2020/8164703
   PubMed Web of Science ®Google Scholar
• Jones J, Koch DD, Vold S, et al. Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma. J Cataract Refract Surg. 2019;45(9):1305–1315. doi:10.1016/j.jcrs.2019.03.024
   PubMed Web of Science ®Google Scholar
• Kozera M, Konopińska J, Mariak Z, Rękas M. Effectiveness of iStent Trabecular Microbypass System Combined with Phacoemulsification versus Phacoemulsification Alone in Patients with Glaucoma and Cataract Depending on the Initial Intraocular Pressure. Ophthalmic Res. 2021;64(2):327–336. doi:10.1159/000511456
   PubMed Web of Science ®Google Scholar
• Ahmed IIK, Fea A, Au L, et al. A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: the COMPARE Study. Ophthalmology. 2020;127(1):52–61. doi:10.1016/j.ophtha.2019.04.034
   PubMed Web of Science ®Google Scholar
• Garg A, Vickerstaff V, Nathwani N, et al. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial. Ophthalmology. 2019;126(9):1238–1248. doi:10.1016/j.ophtha.2019.04.012
   PubMed Web of Science ®Google Scholar
• Khaimi MA. Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery. Therapeutic Adv Ophthalmol. 2021;13:25158414211045751. doi:10.1177/25158414211045751
   Web of Science ®Google Scholar
• Floriani I, Quaranta L, Rulli E, et al. Health-related quality of life in patients with primary open-angle glaucoma. An Italian multicentre observational study. Acta Ophthalmol. 2016;94(5):e278–e286. doi:10.1111/aos.12890
   PubMed Web of Science ®Google Scholar
• Garg A, Hood DC, Pensec N, Liebmann JM, Blumberg DM. Macular Damage, as Determined by Structure-Function Staging, Is Associated With Worse Vision-related Quality of Life in Early Glaucoma. Am J Ophthalmol. 2018;194:88–94. doi:10.1016/j.ajo.2018.07.011
   PubMed Web of Science ®Google Scholar
• Kong XM, Zhu WQ, Hong JX, Sun XH. Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ open. 2014;4(5):e004632. doi:10.1136/bmjopen-2013-004632
   PubMed Web of Science ®Google Scholar
• Riva I, Legramandi L, Rulli E, et al. Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients. Sci Rep. 2019;9(1):6735. doi:10.1038/s41598-019-43203-9
   PubMedGoogle Scholar
• Schweitzer JA, Hauser WH, Ibach M, et al. Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification. Ophthalmol Therapy. 2020;9(4):941–953. doi:10.1007/s40123-020-00290-6
   Web of Science ®Google Scholar
• Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153(1):1–9.e2. doi:10.1016/j.ajo.2011.05.033
   PubMed Web of Science ®Google Scholar
• Wolfram C, Lorenz K, Breitscheidel L, Verboven Y, Pfeiffer N. Health- and vision-related quality of life in patients with ocular hypertension or primary open-angle glaucoma. Ophthalmologica J Int D’ophtalmologie Int J Ophthalmol Zeitschrift Fur Augenheilkunde. 2013;229(4):227–234. doi:10.1159/000350553
   Google Scholar
• Yang Y, Trope GE, Buys YM, et al. Glaucoma Severity and Participation in Diverse Social Roles: does Visual Field Loss Matter? J Glaucoma. 2016;25(7):e697–703. doi:10.1097/IJG.0000000000000353
   Web of Science ®Google Scholar
• Samuelson TW, Singh IP, Williamson BK, et al. Quality of Life in Primary Open-Angle Glaucoma and Cataract: an Analysis of VFQ-25 and OSDI From the iStent inject® Pivotal Trial. Am J Ophthalmol. 2021;229:220–229. doi:10.1016/j.ajo.2021.03.007
   PubMed Web of Science ®Google Scholar
• Lorenz K, Wolfram C, Breitscheidel L, Shlaen M, Verboven Y, Pfeiffer N. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany. Graefe’s Arch Clin Exp Ophthalmol. 2013;251(8):2019–2028. doi:10.1007/s00417-013-2354-z
   Web of Science ®Google Scholar
• Lazcano-Gomez G, Ramos-Cadena MLA, Torres-Tamayo M. Cost of glaucoma treatment in a developing country over a 5-year period. Medicine. 2016;95(47):e5341. doi:10.1097/MD.0000000000005341
   PubMed Web of Science ®Google Scholar
• Guedes RAP, Guedes VMP, Gomes CEM, Chaoubah A. Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity. Medicine. 2016;95(52):e5745. doi:10.1097/MD.0000000000005745
   PubMed Web of Science ®Google Scholar
• Shih V, Parekh M, Multani JK, et al. Clinical and Economic Burden of Glaucoma by Disease Severity: a United States Claims-Based Analysis. Ophthalmol Glaucoma. 2021;4(5):490–503. doi:10.1016/j.ogla.2020.12.007
   PubMedGoogle Scholar
• Tan SZ, Au L. Manchester iStent study: 3-year results and cost analysis. Eye. 2016;30(10):1365–1370. doi:10.1038/eye.2016.139
   PubMed Web of Science ®Google Scholar
• Igarashi A, Falvey H, Chu A, Ueyama M, Zhou J, Onishi Y. PMD13 Cost-Utility Analysis Of Istent Inject In Mild To Moderate Primary Open-Angle Glaucoma In Japan. Value in Health. 2019;22:S671. doi:10.1016/j.jval.2019.09.1426
   Web of Science ®Google Scholar
• Fea AM, Cattel F, Gandolfi S, Buseghin G, Furneri G, Costagliola C. Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy. BMC Health Serv Res. 2021;21(1):824. doi:10.1186/s12913-021-06862-x
   PubMed Web of Science ®Google Scholar
• Mudd A, Nieland K, Kleintjens J, Gicquel G, Falvey H. PRM43 - A Cost-Utility Analysis Of The Istent Inject Trabecular Micro-Bypass System Plus Cataract Surgery In Patients With Mild-To-Moderate Open-Angle Glaucoma In France. Value in Health. 2018;21:S362–S363. doi:10.1016/j.jval.2018.09.2166
   Web of Science ®Google Scholar
• Ahmed I, Ferrufino C, Singh K, Mattox C, Bilir S. Cost-effectiveness of Hydrus plus cataract surgery compared to cataract surgery alone in the United States. J Manag Care Spec Pharm. 2020;26(10):S53–S54.
   Google Scholar
• Nieland K, Labbé A, Schweitzer C, et al. A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France. PLoS One. 2021;16(6):e0252130. doi:10.1371/journal.pone.0252130
   PubMed Web of Science ®Google Scholar
• Patel V, Ahmed I, Podbielski D, Falvey H, Murray J, Goeree R. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J Med Econ. 2019;22(4):390–401. doi:10.1080/13696998.2019.1572013
   PubMed Web of Science ®Google Scholar
• Ahmed IIK, Podbielski DW, Patel V, et al. A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma. Ophthalmol Glaucoma. 2020;3(2):103–113. doi:10.1016/j.ogla.2019.11.009
   PubMedGoogle Scholar
• Sood S, Heilenbach N, Sanchez V, Glied S, Chen S, Al-Aswad LA. Cost-Effectiveness Analysis of Minimally Invasive Trabecular Meshwork Stents with Phacoemulsification. Ophthalmol Glaucoma. 2021;5(3):284–296. doi:10.1016/j.ogla.2021.09.006
   Google Scholar
• Martínez-de-la-Casa JM, Amaro-Barra A, Teus MA, Vila-Arteaga J, Oyagüez I, Martínez C. Budget impact analysis of the XEN® gel stent implant for glaucoma treatment. Expert Rev Ophthalmol. 2019;14(1):5–13. doi:10.1080/17469899.2018.1560264
   Web of Science ®Google Scholar
• Teus MA, Belda JI, Lavín C, et al. Cost-effectiveness analysis of iStent Inject® implantation during cataract surgery compared to cataract surgery alone for mild to moderate open-angle glaucoma patients in Spain. Expert Rev Ophthalmol. 2021;16(4):319–328. doi:10.1080/17469899.2021.1939685
   Web of Science ®Google Scholar
• Garg A, Vickerstaff V, Nathwani N, et al. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial. Ophthalmology. 2020;127(4):467–476. doi:10.1016/j.ophtha.2019.10.023
   PubMed Web of Science ®Google Scholar
• Ventura-Abreu N, García-Feijoo J, Pazos M, Biarnés M, Morales-Fernández L, Martínez-de-la-Casa JM. Twelve-month results of ab interno trabeculectomy with Kahook Dual Blade: an interventional, randomized, controlled clinical study. Graefe’s Arch Clin Exp Ophthalmol. 2021;259(9):2771–2781. doi:10.1007/s00417-021-05213-0
   PubMed Web of Science ®Google Scholar
• Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38(8):1339–1345. doi:10.1016/j.jcrs.2012.03.025
   PubMed Web of Science ®Google Scholar
• Nganga Ngabou CGF, Makita C, Ndalla SS, Nkokolo F, Madzou M. Baisse de la pression intraoculaire après chirurgie manuelle de la cataracte par petite incision [Intraocular pressure decrease after manual small incision cataract surgery]. J Francais D’ophtalmologie. 2017;40(5):397–402. French. doi:10.1016/j.jfo.2016.12.011
   Google Scholar
• Agrawal P, Bradshaw S. Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma. Ophthalmol Therapy. 2018;7(1):49–73. doi:10.1007/s40123-018-0131-0
   PubMed Web of Science ®Google Scholar
• Gillmann K, Mansouri K. Minimally Invasive Glaucoma Surgery: where Is the Evidence? Asia Pac J Ophthalmol. 2020;9(3):203–214. doi:10.1097/APO.0000000000000294
   PubMed Web of Science ®Google Scholar
• Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0183142. doi:10.1371/journal.pone.0183142
   PubMed Web of Science ®Google Scholar
• Gallardo MJ, Dhamdhere K, Dickerson JE. Canaloplasty and Trabeculotomy Ab Interno Combined with Cataract Surgery: 12-Month Outcomes in Hispanic Patients with Open-Angle Glaucoma. Clin Ophthalmol. 2022;16:905–908. doi:10.2147/OPTH.S358878
   PubMed Web of Science ®Google Scholar
• Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, Fernández-Pérez C, García-Sánchez J, García-Feijoó J. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol. 2012;96(5):645–649. doi:10.1136/bjophthalmol-2011-300218
   PubMed Web of Science ®Google Scholar
• Chansangpetch S, Ittarat M, Yang S, et al. Comparison of 1-Year Effectiveness of Trabecular Microbypass Stent implantation (iStent) in Conjunction With Phacoemulsification Among Mild, Moderate, and Severe Primary Open-angle Glaucoma Patients. J Glaucoma. 2020;29(7):542–549. doi:10.1097/IJG.0000000000001542
   Web of Science ®Google Scholar
• ElMallah MK, Berdahl JP, Williamson BK, et al. Twelve-Month Outcomes of Stand-Alone Excisional Goniotomy in Mild to Severe Glaucoma. Clin Ophthalmol. 2020;14:1891–1897. doi:10.2147/OPTH.S256423
   PubMed Web of Science ®Google Scholar
• Ferguson TJ, Berdahl JP, Schweitzer JA, Sudhagoni R. Evaluation of a Trabecular Micro-Bypass Stent in Pseudophakic Patients With Open-Angle Glaucoma. J Glaucoma. 2016;25(11):896–900. doi:10.1097/IJG.0000000000000529
   PubMed Web of Science ®Google Scholar
• Ferguson TJ, Berdahl JP, Schweitzer JA, Sudhagoni RG. Clinical evaluation of a trabecular microbypass stent with phacoemulsification in patients with open-angle glaucoma and cataract. Clin Ophthalmol. 2016;10:1767–1773. doi:10.2147/OPTH.S114306
   PubMed Web of Science ®Google Scholar
• Ferguson TJ, Swan RJ, Bleeker A, et al. Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results. J Cataract Refract Surg. 2020;46(9):1284–1289. doi:10.1097/j.jcrs.0000000000000243
   Web of Science ®Google Scholar
• Ferguson TJ, Mechels KB, Dockter Z, et al. iStent Trabecular Microbypass Stent Implantation with Phacoemulsification in Patients with Open-Angle Glaucoma: 6-Year Outcomes. Clin Ophthalmol. 2020;14:1859–1866. doi:10.2147/OPTH.S247910
   PubMed Web of Science ®Google Scholar
• Gillmann K, Mansouri K, Ambresin A, Bravetti GE, Mermoud A, Prospective A. Analysis of iStent Inject Microstent Implantation: surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months. J Glaucoma. 2020;29(8):639–647. doi:10.1097/IJG.0000000000001546
   PubMed Web of Science ®Google Scholar
• Gonnermann J, Bertelmann E, Pahlitzsch M, Maier-Wenzel AB, Torun N, Klamann MK. Contralateral eye comparison study in MICS & MIGS: trabectome® vs. iStent inject®. Graefe’s Arch Clin Exp Ophthalmol. 2017;255(2):359–365. doi:10.1007/s00417-016-3514-8
   Web of Science ®Google Scholar
• Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. Intermediate Results of iStent or iStent inject Implantation Combined with Cataract Surgery in a Real-World Setting: a Longitudinal Retrospective Study. Ophthalmol Therapy. 2019;8(1):87–100. doi:10.1007/s40123-019-0166-x
   PubMed Web of Science ®Google Scholar
• Guedes RAP, Gravina DM, Guedes VMP, Chaoubah A. Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery. Clin Ophthalmol. 2021;15:1861–1873. doi:10.2147/OPTH.S302684
   Web of Science ®Google Scholar
• Hirsch L, Cotliar J, Vold S, et al. Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study. J Cataract Refract Surg. 2021;47(7):907–915. doi:10.1097/j.jcrs.0000000000000552
   PubMed Web of Science ®Google Scholar
• Hooshmand J, Rothschild P, Allen P, Kerr NM, Vote BJ, Toh T. Minimally invasive glaucoma surgery: comparison of iStent with iStent inject in primary open angle glaucoma. Clin Experiment Ophthalmol. 2019;47(7):898–903. doi:10.1111/ceo.13526
   Web of Science ®Google Scholar
• Hughes T, Traynor M. Clinical Results of Ab Interno Canaloplasty in Patients with Open-Angle Glaucoma. Clin Ophthalmol. 2020;14:3641–3650. doi:10.2147/OPTH.S275087
   PubMed Web of Science ®Google Scholar
• Ibáñez-Muñoz A, Soto-Biforcos VS, Rodríguez-Vicente L, et al. XEN implant in primary and secondary open-angle glaucoma: a 12-month retrospective study. Eur J Ophthalmol. 2020;30(5):1034–1041. doi:10.1177/1120672119845226
   PubMed Web of Science ®Google Scholar
• Khan M, Saheb H, Neelakantan A, et al. Efficacy and safety of combined cataract surgery with 2 trabecular microbypass stents versus ab interno trabeculotomy. J Cataract Refract Surg. 2015;41(8):1716–1724. doi:10.1016/j.jcrs.2014.12.061
   PubMed Web of Science ®Google Scholar
• Klamann MK, Gonnermann J, Pahlitzsch M, et al. iStent inject in phakic open angle glaucoma. Graefe’s Arch Clin Exp Ophthalmol. 2015;253(6):941–947. doi:10.1007/s00417-015-3014-2
   Web of Science ®Google Scholar
• Le C, Kazaryan S, Hubbell M, Zurakowski D, Ayyala RS. Surgical Outcomes of Phacoemulsification Followed by iStent Implantation Versus Goniotomy With the Kahook Dual Blade in Patients With Mild Primary Open-angle Glaucoma With a Minimum of 12-Month Follow-up. J Glaucoma. 2019;28(5):411–414. doi:10.1097/IJG.0000000000001143
   PubMed Web of Science ®Google Scholar
• Lee D, King J, Thomsen S, Hirabayashi M, An J. Comparison Of Surgical Outcomes Between Excisional Goniotomy Using The Kahook Dual Blade And iStent Trabecular Micro-Bypass Stent In Combination With Phacoemulsification. Clin Ophthalmol. 2019;13:2097–2102. doi:10.2147/OPTH.S224109
   PubMed Web of Science ®Google Scholar
• Lee GA, Porter AJ, Vincent RA, Makk J, Vincent SJ. Combined phacoemulsification and microinvasive glaucoma surgery in comparison to phacoemulsification alone for open angle glaucoma. Eye. 2020;34(2):312–318. doi:10.1038/s41433-019-0459-2
   Web of Science ®Google Scholar
• Maier AB, Arani P, Pahlitzsch M, et al. Influence of Selective Laser Trabeculoplasty (SLT) on the iStent inject® outcomes. BMC Ophthalmol. 2020;20(1):457. doi:10.1186/s12886-020-01723-3
   Web of Science ®Google Scholar
• Ondrejka S, Körber N. 360° ab-interno Schlemm’s canal viscodilation in primary open-angle glaucoma. Clin Ophthalmol. 2019;13:1235–1246. doi:10.2147/OPTH.S203917
   Web of Science ®Google Scholar
• Pahlitzsch M, Davids AM, Winterhalter S, et al. Selective Laser Trabeculoplasty Versus MIGS: forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma. Ophthalmol Therapy. 2021;10(3):509–524. doi:10.1007/s40123-021-00347-0
   Web of Science ®Google Scholar
• Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 2021;100(3):e779–e790. doi:10.1111/aos.14968
   Web of Science ®Google Scholar
• Salby AM, Skalicky SE. Combined iStent(®) Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma. Clin Ophthalmol. 2020;14:985–993. doi:10.2147/OPTH.S241628
   Web of Science ®Google Scholar
• Salimi A, Clement C, Shiu M, Harasymowycz P. Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: one-Year Outcomes of a Multi-Centre Study. Ophthalmol Therapy. 2020;9(3):585–596. doi:10.1007/s40123-020-00266-6
   Web of Science ®Google Scholar
• Salimi A, Watt H, Harasymowycz P. Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities. J Glaucoma. 2021;30(3):266–275. doi:10.1097/IJG.0000000000001716
   PubMed Web of Science ®Google Scholar
• Seibold LK, Gamett KM, Kennedy JB, et al. Outcomes after combined phacoemulsification and trabecular microbypass stent implantation in controlled open-angle glaucoma. J Cataract Refract Surg. 2016;42(9):1332–1338. doi:10.1016/j.jcrs.2016.07.023
   PubMed Web of Science ®Google Scholar
• Silveira Seixas RC, Balbino M, Basile Neto A. Mid-Term Evaluation of iStent Inject(®) Trabecular Micro-Bypass Stent Implantation with or without Phacoemulsification: a Retrospective Study. Clin Ophthalmol. 2020;14:4403–4413. doi:10.2147/OPTH.S283587
   Web of Science ®Google Scholar
• Shazly TA, Latina MA. Intraocular pressure response to selective laser trabeculoplasty in the first treated eye vs the fellow eye. Arch Ophthalmol. 2011;129(6):699–702. doi:10.1001/archophthalmol.2011.108
   Google Scholar
• Toneatto G, Zeppieri M, Papa V, et al. 360° Ab-Interno Schlemm’s Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma-Midterm Results. J clin med. 2022;11:1. doi:10.3390/jcm11010259
   Web of Science ®Google Scholar
• Vold SD, Williamson BK, Hirsch L, et al. Canaloplasty and Trabeculotomy with the OMNI System in Pseudophakic Patients with Open-Angle Glaucoma: the ROMEO Study. Ophthalmol Glaucoma. 2021;4(2):173–181. doi:10.1016/j.ogla.2020.10.001
   PubMedGoogle Scholar
• Weiner AJ, Weiner Y, Weiner A. Intraocular Pressure After Cataract Surgery Combined With Ab Interno Trabeculectomy Versus Trabecular Micro-bypass Stent: an Intrasubject Same-surgeon Comparison. J Glaucoma. 2020;29(9):773–782. doi:10.1097/IJG.0000000000001547
   Web of Science ®Google Scholar
• Dirani M, Crowston JG, Taylor PS, et al. Economic impact of primary open-angle glaucoma in Australia. Clin Experiment Ophthalmol. 2011;39(7):623–632. doi:10.1111/j.1442-9071.2011.02530.x
   PubMed Web of Science ®Google Scholar
• Singh IP, Sarkisian S, Hornbeak D, Katz LJ, Samuelson T. Treatment Success Across Different Levels of Preoperative Disease Burden: stratified Two-Year Outcomes from the Pivotal Trial of iStent inject (®) Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. Clin Ophthalmol. 2021;15:3231–3240. doi:10.2147/OPTH.S316270
   Web of Science ®Google Scholar